vTv Therapeutics | 8-K: Current report
vTv Therapeutics | 8-K: vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update
vTv Therapeutics | DEF 14A: Definitive information statements
vTv Therapeutics | S-3: Registration statement for specified transactions by certain issuers
vTv Therapeutics | 8-K: Current report
vTv Therapeutics | 8-K: Current report
vTv Therapeutics | 8-K: vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
vTv Therapeutics | 8-K: Current report
vTv Therapeutics | 8-K: Current report
vTv Therapeutics | 8-K: Current report
vTv Therapeutics | 8-K: Current report
vTv Therapeutics | 8-K: Current report
vTv Therapeutics | 8-K: Current report
vTv Therapeutics | 8-K: Current report
vTv Therapeutics | 8-K: Current report
vTv Therapeutics | 8-K: Current report
vTv Therapeutics | 8-K: vTv Therapeutics Announces 2023 Third Quarter Financial Results and Provides Corporate Update
vTv Therapeutics | 8-K: Current report
vTv Therapeutics | DEF 14C: Definitive information statements
vTv Therapeutics | 8-K: vTv Therapeutics Announces 2023 Second Quarter Financial Results and Provides Corporate Update
No Data